Top Page
Delta Drone International Ltd
(Sydney:RKT)
Delta Drone International Ltd (RKT) vs. iShares MSCI Australia ETF (EWA)
Delta Drone International Ltd Business Overview & Revenue Model
Delta Drone International Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.09M | 7.24M | 6.14M | 5.73M | 4.58M |
| Gross Profit | 2.94M | 3.64M | 3.13M | 2.80M | 2.43M |
| EBITDA | -1.47M | -1.03M | -1.43M | -1.98M | -1.63M |
| Net Income | -2.32M | -1.92M | -1.77M | -1.92M | -3.62M |
Balance Sheet | |||||
| Total Assets | 8.10M | 8.35M | 6.81M | 6.97M | 10.28M |
| Cash, Cash Equivalents and Short-Term Investments | 1.74M | 3.45M | 2.38M | 2.31M | 989.78K |
| Total Debt | 1.70M | 1.34M | 1.17M | 380.78K | 733.04K |
| Total Liabilities | 3.12M | 2.50M | 2.18M | 1.32M | 3.55M |
| Stockholders Equity | 5.26M | 6.18M | 4.92M | 5.59M | 8.04M |
Cash Flow | |||||
| Free Cash Flow | -2.80M | -1.73M | -1.90M | -2.34M | -2.43M |
| Operating Cash Flow | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -1.99M | -1.16M | -56.51K | 3.25M | -498.27K |
| Financing Cash Flow | 3.23M | 2.72M | 1.12M | -355.46K | -165.27K |
Delta Drone International Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | AU$39.03M | -11.38 | -49.17% | ― | ― | ― | |
47 Neutral | AU$14.38M | -5.79 | -166.26% | ― | 24.43% | 40.63% | |
47 Neutral | AU$10.47M | -11.04 | -76.21% | ― | 106.54% | 74.33% | |
44 Neutral | AU$7.32M | -2.63 | ― | ― | 13.07% | 68.60% | |
38 Underperform | AU$7.95M | -0.59 | -135.89% | ― | -21.60% | -657.00% |
Delta Drone International Ltd Corporate Events
RocketDNA Ltd., listed on the ASX under the code RKT, has lodged a notice with the exchange outlining a proposed issue of new securities via a placement or similar capital-raising mechanism. The company did not include additional operational or strategic details about its business activities in the filing.
RocketDNA plans to issue up to 5 million options (ASX code RKTAB), each with an exercise price of $0.02 and an expiry date of 30 May 2029, with a proposed issue date of 19 January 2026. The move signals an intention to bolster its capital structure through option-based financing, potentially providing future funding flexibility and aligning investor participation with the company’s longer-term share price performance.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has announced that a performance milestone has been met, triggering the vesting of 4 million 2025 Performance Rights held by Managing Director Chris Clark and 2 million held by executive director Paul Williamson. The milestone was achieved after the company reached a 30-day volume-weighted average price of A$0.02 for its shares within the specified assessment period, and each vested right can now be exercised into one fully paid ordinary share for nil consideration before 30 September 2026, potentially increasing the company’s share count and further aligning executive incentives with shareholder value.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has issued 617,984 fully paid ordinary shares to employees under its Employee Incentive Plan, expanding its share capital without undertaking a formal prospectus or disclosure process under Part 6D.2 of the Corporations Act. The company confirmed it remains compliant with its financial reporting and continuous disclosure obligations and stated there is no excluded information that would be material to investors’ assessment of RocketDNA’s financial position or the rights attached to its securities, signaling that the issuance is an administrative step in employee compensation rather than a move tied to undisclosed developments.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has notified the market of the issuance of 4.5 million unquoted performance rights to employees under its 2025 employee incentive scheme, effective 7 January 2026. The move underscores the company’s use of equity-based remuneration to attract and retain key staff, aligning employee incentives with shareholder interests and signalling ongoing investment in human capital to support its growth and operational objectives.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd. has applied to the ASX for quotation of 617,984 new fully paid ordinary shares, issued on 7 January 2026 under its employee incentive plan approved by shareholders in May 2024. The move modestly increases the company’s quoted capital base and underscores its continued use of equity-based remuneration to attract and retain staff, aligning employees’ interests with those of shareholders and signalling an ongoing commitment to incentivising key talent in a competitive technology sector.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
RocketDNA Ltd has announced that a performance milestone has been met, triggering the full vesting of 3,000,000 performance rights held by Managing Director and CEO Chris Clark and 1,500,000 performance rights held by executive director Paul Williamson. The vesting was tied to the company achieving a total shareholder return of 100%, reflected in the rise of the 10-day volume-weighted average share price from $0.0106 at issuance of the 2023 performance rights to $0.0235 as at 2 January 2026, and each right can now be exercised into one fully paid ordinary share at no cost before 29 May 2027, signalling both a significant uplift in shareholder value and the realisation of executive long-term incentive targets.
The most recent analyst rating on (AU:RKT) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Delta Drone International Ltd stock, see the AU:RKT Stock Forecast page.
Pither Investments Pty Ltd and Nintieth Y Pty Ltd have ceased to be substantial shareholders in Rocketdna Ltd, as disclosed in a statutory notice lodged under the Corporations Act. The change, effective 24 December 2025 and attributed to dilution and trading, reduces their voting influence in the company and signals a shift in Rocketdna’s share register that existing and prospective investors may factor into their assessment of the stock’s ownership dynamics.
RocketDNA Ltd has disclosed a change in the holdings of director Paul Williamson, who acquired 1,333,333 ordinary fully paid shares on 24 December 2025 through participation in the second tranche of a shareholder-approved placement. Following the $20,000 on-market investment, Williamson’s direct holding increased to 7,273,503 ordinary shares, alongside his existing 12 million performance rights and 15 million options with staggered expiries to 2031, signalling continued director support for the company’s capital-raising efforts and long-term strategy.
RocketDNA Ltd has disclosed a change in director David Morton’s indirect interest in the company’s securities, as required under ASX listing rules. Through an associated holder, Morton acquired 6,666,666 additional ordinary fully paid shares on 24 December 2025 for a consideration of $100,000, increasing his indirect shareholding in RocketDNA. The notice formalises the transaction for regulatory transparency and signals a further financial commitment by a board member, which may be interpreted by investors as a vote of confidence in the company’s prospects.
RocketDNA Ltd has disclosed a change in the interests of director Chris Clark, whose holdings are held indirectly via C & K Clark SMSF Pty Ltd. Clark acquired 666,666 additional ordinary fully paid shares for $10,000 through participation in tranche two of a previously approved placement, increasing his indirect shareholding while leaving his existing performance rights and options unchanged. The transaction, endorsed by shareholders at a general meeting on 18 December 2025, modestly strengthens insider ownership and signals continued board-level support for the company’s capital-raising activities and strategic direction.
RocketDNA Ltd has issued 45,199,993 new ordinary fully paid shares at $0.015 per share as part of a placement previously announced to the market and approved by shareholders at a recent general meeting. The company confirmed that the shares were issued without a prospectus under the relevant exemption in the Corporations Act, that it remains compliant with its financial reporting and continuous disclosure obligations, and that there is no excluded information that investors would reasonably require, underscoring regulatory compliance and transparency around the capital raising for existing and prospective shareholders.
RocketDNA Ltd has applied to the ASX for quotation of 45,199,993 new fully paid ordinary shares under code RKT, following the issue of these securities on 24 December 2025. The move expands the company’s quoted capital base and formalises the trading status of shares previously flagged to the market, potentially enhancing liquidity for existing investors and supporting RocketDNA’s capacity to pursue future corporate and operational initiatives.
RocketDNA Ltd has invited shareholders and interested investors to an online webinar on 23 December 2025, where Managing Director and CEO Christopher Clark will brief the market on recent operational progress and customer activity. The session will cover new contracts and purchase orders, the company’s first deployment into BHP’s iron ore operations, expansion across existing clients in Australia and Africa, progress in scaling its autonomous drone services and software, and near-term operational priorities heading into 2026, offering investors additional context on growth opportunities and the company’s evolving market position.
RocketDNA Ltd announced the successful passage of all resolutions at its General Meeting held on December 18, 2025. The resolutions, including the ratification and approval of recent share placements, signal stakeholder confidence and provide the necessary financial flexibility to support RocketDNA’s strategic growth initiatives. These measures are important for maintaining the company’s competitive edge in its core industries and markets.
RocketDNA Ltd has secured approximately A$1 million in new orders from existing clients, reflecting a growing demand for their autonomous drone solutions in the mining sector. The company has expanded its xBot deployments across Australia and secured contracts with major mining companies such as BHP and Assmang, enhancing their market presence and operational capabilities. These developments indicate RocketDNA’s strong positioning to meet increasing industry demand for automation and safety improvements, with plans to further develop their software offerings to support long-term growth.
RocketDNA Ltd. announced the cessation of 10 million securities, specifically options expiring on December 7, 2025, due to their expiry without exercise or conversion. This announcement reflects a routine update on the company’s issued capital, indicating a reduction in potential future equity dilution, which may impact investor perceptions and the company’s capital structure.
Altor Capital Pty Ltd has ceased to be a substantial holder in RocketDNA Limited as of November 28, 2025. This change in holding involved the sale of a significant number of ordinary shares, totaling 69,294,871, which may impact RocketDNA’s shareholder structure and potentially influence the company’s market perception.
RocketDNA Ltd has announced a General Meeting for its shareholders, which will be held virtually on December 18, 2025. The meeting will allow shareholders to participate online, where they can listen, ask questions, and vote on resolutions. Key resolutions include the ratification of prior issues of shares and the approval to issue additional shares to professional and sophisticated investors. This meeting is significant as it addresses important share placements that could impact the company’s capital structure and investor relations.
RocketDNA Ltd, listed on the ASX under the ticker RKT, has issued 221,466,667 ordinary fully paid shares at a price of $0.015 per share. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act, and the company has confirmed compliance with relevant regulatory provisions. The announcement indicates that there is no excluded information that would impact investors’ assessments of the company’s financial position or the rights and liabilities of the securities.
RocketDNA Ltd. has announced the quotation of 221,466,667 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code RKT. This move is part of a transaction previously announced and is expected to enhance the company’s market presence and liquidity, potentially impacting its stakeholders positively.
RocketDNA Ltd, a leader in AI-powered drone solutions, has secured a significant order from Kumba Iron Ore Limited, part of Anglo American Plc, to supply and integrate seven xBot® systems at the Sishen Mine in South Africa. This order, valued at approximately A$580,000, includes delivery, integration, training, and the setup of a control room for centralized operations. This engagement marks a strategic partnership with a leading mining company, enhancing RocketDNA’s presence in the mining sector and supporting its goal of expanding autonomous drone operations globally.
RocketDNA Ltd. has announced a proposed issuance of 45,200,000 ordinary fully paid securities, with the issue date set for December 31, 2025. This move is part of a placement or other type of issue, and it is expected to impact the company’s operations by potentially increasing its capital base, which could enhance its market positioning and provide more opportunities for growth.
RocketDNA Ltd. has announced a proposed issue of 221,466,667 ordinary fully paid securities, scheduled for November 11, 2025. This move is part of a placement or other type of issue, indicating a potential strategy to raise capital or expand its shareholder base, which could impact the company’s market positioning and stakeholder interests.
RocketDNA Ltd has successfully raised $4.0 million through a placement at $0.015 per share, with strong backing from institutional and strategic investors. The funds will be used for the production of xBot® units, development of Skylink and SiteTube® software, and working capital, following recent contract wins with BHP Mitsubishi Alliance and Gold Fields, reinforcing RocketDNA’s position as a leader in autonomous drone operations for mining and critical infrastructure.
RocketDNA Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RKT, has requested a trading halt on its securities pending an upcoming announcement regarding a placement. The halt will remain in effect until the announcement is made or until the market opens on Monday, 3 November 2025, whichever comes first. This move indicates that RocketDNA is preparing to release significant information that could impact its market position and stakeholder interests.
RocketDNA Ltd reported a 13% increase in quarterly revenue to $1.875 million, driven by a 40% rise in xBot revenue. The company secured significant contracts in Australia and Africa, including a 3-year contract at Gruyere Gold Mine and a 9-month contract with BHP Mitsubishi Alliance. These developments highlight RocketDNA’s strategic shift towards autonomous systems, addressing labor shortages in mining and expanding its technology’s role in daily operations. The adoption of SiteTube® software across multiple departments underscores the company’s growing importance to Tier-1 mining customers.
RocketDNA Ltd has announced the receipt of additional purchase orders from BHP Mitsubishi Alliance for the operation of six dual SurveyBot units, valued at approximately $1 million, to be executed from January to June 2026. This follows a previous order of $450,000 and highlights the company’s growing role in providing geospatial data for mine planning and environmental management, signaling potential growth opportunities in the mining industry.
RocketDNA Ltd has secured additional purchase orders from BHP Mitsubishi Alliance for the operation of six dual SurveyBot units from January to June 2026, with a contract value of approximately $1 million. This agreement highlights RocketDNA’s ongoing partnership with major mining clients and reinforces its position as a key player in providing drone-based geospatial data solutions for the mining industry.
RocketDNA Limited, a company listed on the Australian Securities Exchange, has released a presentation outlining its current position and future prospects. The document emphasizes that the information provided is not a financial or investment advice and cautions investors about the inherent risks and uncertainties in forward-looking statements. The company disclaims any obligation to update these statements, highlighting the importance of independent assessment by potential investors.